Abstract:Chronic obstructive pulmonary disease (COPD) is characterized by aberrant inflammatory and repair responses, leading to bronchitis, small airway remodeling, and emphysema. It is the third leading cause of death worldwide and is caused by exposure to tobacco smoke or environmental pollutants (1). Importantly, the inflammatory processes in COPD are known to persist long after smoking cessation (2). However, the underlying mechanisms that initiate and drive inflammation are still not clear, and currently, no pharmacological treatments are available to alter the course of the disease. These mechanisms include defective epithelial repair in the airways and alveoli, suggesting that the endogenous lung stem cells may be the initial drivers of the disease. In line with that, research has demonstrated that basal (stem) cells in the airway are among the first cells to be affected by inhaled toxins, resulting in epithelial damage, defective repair, and subsequent inflammation (3, 4). The mechanisms triggering the initiation of this inflammation are not understood, but it is clear that the epithelial cells are in constant communication with the inflammatory cells. It was recently shown that a subpopulation of basal cells can drive the inflammatory processes observed in COPD, suggesting that these inflammatory signals represent a potential therapeutic target to inhibit tissue destruction and promote regeneration of the normal cells that still exist in the airways at end-stage COPD (5, 6). In the alveolar compartment, the alveolar type 2 (AT2) cells are the stem cells responsible for homeostasis and regeneration ( Figure 1A ). Even though AT2 cells have been evaluated in multiple single-cell OMICS studies (7–9), the mechanistic alterations in AT2 cells in COPD are unknown, and the question remains as to whether a disease-propagating subpopulation of AT2 cells exists in COPD. Hence, a deeper understanding of the AT2 cells in patients with COPD is needed to understand their contribution to disease.

Regulation of Alveolar Type 2 Stem/progenitor Cells in Lung Injury and Regeneration

Alveolar type 2 progenitor cells for lung injury repair

Repair and regeneration of the alveolar epithelium in lung injury

Epithelial stem cells and niches in lung alveolar regeneration and diseases

Alveolar Type Ii Cells Possess The Capability Of Initiating Lung Tumor Development

Tracing the origin of alveolar stem cells in lung repair and regeneration

Alveolar epithelial progenitor cells require Nkx2-1 to maintain progenitor-specific epigenomic state during lung homeostasis and regeneration

The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung

Longitudinal single cell transcriptomics reveals Krt8+ alveolar epithelial progenitors in lung regeneration

Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease: Impairing or Improving Disease Outcome?

Acute Lung Injury Associated Milieus Regulate the Plasticity of Type I Alveolar Cells Via KLF2

Characterization of perivascular alveolar epithelial stem cells and their niche in lung homeostasis and cancer

Interplay between pulmonary epithelial stem cells and innate immune cells contribute to the repair and regeneration of ALI/ARDS

Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells

The cellular kinetics of lung alveolar epithelial cells and its relationship with lung tissue repair after acute lung injury

Sex-determining region Y-box 2-positive alveolar cells are responsive to bleomycin-induced lung injury

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis

Diversity of Epithelial Stem Cell Types in Adult Lung

CEBPA restricts alveolar type 2 cell plasticity during development and injury-repair

Lung regeneration: diverse cell types and the therapeutic potential